Natural Cycles Raises $55M in Series C Funding to Expand Contraceptive App and Improve Healthcare Reimbursement
Natural Cycles Closes $55M Series C Financing
Natural Cycles' Series C Funding
Key Highlights:
- Series C Funding: Natural Cycles, a women's health company known for its contraceptive app, raised $55 million in Series C funding.
- Investors: Lauxera Capital Partners led the round, with participation from Point72 Private Investments, J.P. Morgan, EQT Ventures, Samsung Ventures, Heartcore Capital, Headline, and Bonnier Ventures.
- Product and Market Expansion: The funding will be used to accelerate commercial efforts, develop new products, and automate healthcare reimbursement processes.
Natural Cycles' Target Market
- Target Market: Women seeking a natural and non-hormonal contraceptive method.
- Direct-to-Consumer Approach: Individuals interested in managing their fertility and contraception through a mobile app.
- Postpartum Support: New mothers looking for guidance and support during the postpartum period.
What Natural Cycles Needs to Buy
- Marketing and Advertising Services: Agencies specializing in digital marketing and advertising to reach and educate target audiences.
- Product Development and Innovation: Collaborations with technology partners to enhance the app's features and user experience.
- Partnerships with Healthcare Providers: Collaborations with healthcare providers and insurers to streamline reimbursement processes and expand access to the app.